Literature DB >> 27752997

The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis.

Zhen-Yao Chen1, Xin Chen1, Zhao-Xia Wang2.   

Abstract

MicroRNAs are a large group of non-coding RNAs that have emerged as regulators of various biological processes, especially carcinogenesis and cancer progression. Recent evidence has shown that microRNA-196a (miR-196a) is upregulated in most types of tumors and involved in multiple biological processes via translational inhibition and mRNA cleavage, such as cell proliferation, migration, and invasion, mostly functioning as an oncogene. Dysregulation of miR-196a promotes oncogenesis and tumor progression. In this review, we summarize the upstream regulators, target genes, signaling pathways, and single nucleotide polymorphisms of miR-196a, which collectively affect cell proliferation, migration, and invasion. In addition, we review the clinical outcomes and significance of miR-196a. miR-196a may serve as a novel biomarker or target for diagnosis, prognosis, and therapy in several human cancers.

Entities:  

Keywords:  Biomarker; MicroRNA-196a; Prognosis; Tumor progression; Tumorigenesis

Year:  2016        PMID: 27752997     DOI: 10.1007/s13277-016-5430-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  87 in total

Review 1.  Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.

Authors:  Colin W Steele; Karin A Oien; Colin J McKay; Nigel B Jamieson
Journal:  Pancreas       Date:  2011-11       Impact factor: 3.327

2.  miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells.

Authors:  Jie Zhang; Fangxia Zheng; Gang Yu; Yanhua Yin; Qingyang Lu
Journal:  Biochem Biophys Res Commun       Date:  2013-10-10       Impact factor: 3.575

3.  HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.

Authors:  Kideok Jin; Sunju Park; Wei Wen Teo; Preethi Korangath; Sean Soonweng Cho; Takahiro Yoshida; Balázs Győrffy; Chirayu Pankaj Goswami; Harikrishna Nakshatri; Leigh-Ann Cruz; Weiqiang Zhou; Hongkai Ji; Ying Su; Muhammad Ekram; Zhengsheng Wu; Tao Zhu; Kornelia Polyak; Saraswati Sukumar
Journal:  Cancer Discov       Date:  2015-07-15       Impact factor: 39.397

4.  A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis.

Authors:  Xiao-Dong Li; Zhi-Gao Li; Xian-Xu Song; Chun-Fu Liu
Journal:  Pathology       Date:  2010-12       Impact factor: 5.306

5.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

6.  MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.

Authors:  Dipen M Maru; Rajesh R Singh; Christina Hannah; Constance T Albarracin; Yong X Li; Ronald Abraham; Angela M Romans; Hui Yao; Madan G Luthra; Sharmila Anandasabapathy; Stephen G Swisher; Wayne L Hofstetter; Asif Rashid; Rajyalakshmi Luthra
Journal:  Am J Pathol       Date:  2009-03-26       Impact factor: 4.307

7.  MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Hwi Young Kim; Jung-Hwan Yoon; Hyo-Suk Lee; Jae Youn Cheong; Sung Won Cho; Hyoung Doo Shin; Yoon Jun Kim
Journal:  J Med Virol       Date:  2013-11-19       Impact factor: 2.327

Review 8.  Nm23/NDP kinases in hepatocellular carcinoma.

Authors:  Mathieu Boissan; Marie-Lise Lacombe
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 3.853

9.  OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.

Authors:  Ya-Ching Lu; Joseph T Chang; Chun-Ta Liao; Chung-Jan Kang; Shiang-Fu Huang; I-How Chen; Chi-Che Huang; Yu-Chen Huang; Wen-Ho Chen; Chi-Ying Tsai; Hung-Ming Wang; Tzu-Chen Yen; Guo-Rung You; Chang-Hsu Chiang; Ann-Joy Cheng
Journal:  Mol Cancer       Date:  2014-09-19       Impact factor: 27.401

10.  MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1.

Authors:  T Hou; J Ou; X Zhao; X Huang; Y Huang; Y Zhang
Journal:  Br J Cancer       Date:  2014-01-14       Impact factor: 7.640

View more
  6 in total

1.  MicroRNAs profiling in fibroblasts derived from patients with Gorlin syndrome.

Authors:  Tadashi Shiohama; Katsunori Fujii; Toshiyuki Miyashita; Tomozumi Takatani; Hajime Ikehara; Hideki Uchikawa; Toshino Motojima; Tomoko Uchida; Naoki Shimojo
Journal:  J Hum Genet       Date:  2019-05-14       Impact factor: 3.172

2.  Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring.

Authors:  Lechun Lyu; Yu Zhao; Hongquan Lu; Zijie Liu; Jiazhi Guo; Di Lu; Xiang Li
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

3.  A voltammetric assay for microRNA-25 based on the use of amino-functionalized graphene quantum dots and ss- and ds-DNAs as gene probes.

Authors:  Azam Akbarnia; Hamid R Zare
Journal:  Mikrochim Acta       Date:  2018-10-09       Impact factor: 5.833

4.  MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.

Authors:  Tessho Maruyama; Kazuhide Nishihara; Masato Umikawa; Akira Arasaki; Toshiyuki Nakasone; Fumikazu Nimura; Akira Matayoshi; Kimiko Takei; Saori Nakachi; Ken-Ichi Kariya; Naoki Yoshimi
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

5.  Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer.

Authors:  Yi-Fan Xu; Bethany N Hannafon; Yan D Zhao; Russell G Postier; Wei-Qun Ding
Journal:  Oncotarget       Date:  2017-08-18

6.  Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.

Authors:  Marta Rodríguez; Cristina Bajo-Santos; Nina P Hessvik; Susanne Lorenz; Bastian Fromm; Viktor Berge; Kirsten Sandvig; Aija Linē; Alicia Llorente
Journal:  Mol Cancer       Date:  2017-10-05       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.